97.81↑1.91 (1.99%)
04:01 PM,4th Dec 2023BSE : 524632
NSE :
Sector : Health care
ISIN Code : INE551C01028
Last Updated: Dec 04 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin) Anti Biotics (Cephalosporin) Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Emetic Anti Ulcer Beta Blockers Diuretics Analgesic Analgesic (NASID) Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergics Corticosteroids Hyper and Hypoglycemic Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum) Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus) Intas Pharmaceuticals Limited Cadila Pharmaceuticals Limited Makers Laboratories Limited Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 2013-14 the Company got approval from Hon'ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited (Transferor Company) with Relish Pharmaceuticals Limited (Transferee Company) and Re-organization of Share Capital of Relish Pharmaceuticals Limited (Transferee Company) through Scheme of Arrangement vide Hon'ble High Court of Gujarat order dated 20 Dec' 2013.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 105 |
EPS - TTM (₹) [S] | 8.44 |
P/E Ratio (X) [S] | 2.40 |
Face Value (₹) | 10 |
Latest Dividend (%) | 5.00 |
Latest Dividend Date | 15 Sep 2023 |
Dividend Yield (%) | 0.18 |
Book Value Share (₹) [S] | 40.79 |
P/B Ratio (₹) [S] | 2.40 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 97.80 97.81 |
Week Low/High | 85.15 97.81 |
Month Low/High | 85.15 106.00 |
Year Low/High | 25.11 194.00 |
All time Low/High | 0.09 194.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 10.38% | % | 4.39 | 4.51% |
1 Month | -7.76% | % | 6.99 | 7.57% |
3 Month | -34.40% | % | 4.93 | 5.93% |
6 Month | -25.62% | % | 10.10 | 11.61% |
1 Year | 195.59% | % | 9.54 | 10.65% |
3 Year | 1243.54% | % | 52.76 | 56.03% |
Chairman & Managing Director : Dakshesh Shah
Executive Director : Payal Mehta
Independent Director : Bhoomiben Patel
Independent Director : Sarjeevan Singh
Independent Director : Sonal Deepalbhai Gandhi
Executive Director : Sanskruti Patel
Executive Director : Dhruvin Shah
Independent Director : Pinki Nirmal Sagar
Registered Office: 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo,Ahmedabad,Gujarat-380054 Ph: 91-079-66522247/27498515
Email:info@relishpharma.com